Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Haemonetics (HAE) Inventory Average (2016 - 2025)

Haemonetics has reported Inventory Average over the past 16 years, most recently at $328.7 million for Q4 2025.

  • For Q4 2025, Inventory Average rose 84.81% year-over-year to $328.7 million; the TTM value through Dec 2025 reached $328.7 million, up 84.81%, while the annual FY2025 figure was $341.2 million, 18.34% up from the prior year.
  • Inventory Average for Q4 2025 was $328.7 million at Haemonetics, down from $348.4 million in the prior quarter.
  • Over five years, Inventory Average peaked at $377.9 million in Q3 2024 and troughed at $169.4 million in Q1 2025.
  • A 5-year average of $295.8 million and a median of $305.0 million in 2022 define the central range for Inventory Average.
  • On a YoY basis, Inventory Average climbed as much as 84.81% in 2025 and fell as far as 45.47% in 2025.
  • Year by year, Inventory Average stood at $324.6 million in 2021, then dropped by 21.37% to $255.2 million in 2022, then rose by 15.56% to $294.9 million in 2023, then plummeted by 39.7% to $177.9 million in 2024, then skyrocketed by 84.81% to $328.7 million in 2025.
  • Business Quant data shows Inventory Average for HAE at $328.7 million in Q4 2025, $348.4 million in Q3 2025, and $362.8 million in Q2 2025.